Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

M-012

Supelco

(±)-MDA -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonym(e):

(±)-3,4-Methylendioxyamphetamin

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C10H13NO2
CAS-Nummer:
4764-17-4
Molekulargewicht:
179.22
MDL-Nummer:
MFCD00867901
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329817726
NACRES:
NA.24

Qualität

certified reference material

Qualitätsniveau

300

Form

liquid

Leistungsmerkmale

Snap-N-Spike®/Snap-N-Shoot®

Verpackung

ampule of 1 mL

Hersteller/Markenname

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)

Konzentration

1.0 mg/mL in methanol

Methode(n)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Anwendung(en)

forensics and toxicology

Format

single component solution

Lagertemp.

−20°C

SMILES String

NC(C)CC1=CC=C(OCO2)C2=C1

InChI

1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3

InChIKey

NGBBVGZWCFBOGO-UHFFFAOYSA-N

Verwandte Kategorien

Allgemeine Beschreibung

Ein zertifizierter Lösungsstandard, der sich zur Verwendung in LC/MS- oder GC/MS-Anwendungen in der klinischen Toxikologie, forensischen Analytik oder für Drogentests im Urin eignet. MDA, oder 3,4-Methylendioxyamphetamin, ist eine illegale Freizeitdroge der Klassen Amphetamin und Phenethylamin. Das auch als Tenamphetamin bekannte MDA wird aufgrund seiner psychedelischen und halluzinogenen Wirkung, die der von MDMA (Ecstasy) ähneln, konsumiert.

Anwendung

  • MDA Research Chemical: (±)-MDA solution is extensively used in scientific research to study its pharmacological properties, including its effects on neurotransmitter systems which are critical in understanding substance-related disorders.
  • MDA Enantiomers: The solution includes both enantiomers of MDA, allowing for detailed studies on the differential biological activities of each enantiomer in neuropharmacological research.
  • Synthetic MDA Solution: This synthetic solution is crucial for controlled studies in biochemistry and pharmacology, providing a consistent baseline for experimental reproducibility and validation.
  • MDA Biochemistry Application: Utilized in biochemical assays, (±)-MDA solution helps in the exploration of its metabolic pathways and interactions with biological macromolecules, enhancing the understanding of its pharmacodynamics.
  • MDA Pharmacological Studies: As a key tool in pharmacological research, (±)-MDA solution is used to investigate its potential therapeutic effects and risks, contributing to the development of safety guidelines and therapeutic protocols.

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

A-050

Amin-Mischung 6 -Lösung, 250 μg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-010

(±)-MDA-D5 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-011

(±)-MDMA-D5 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-013

(±)-MDMA -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-027

(±)-MDA-D5 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-029

(±)-MDMA-D5 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-065

(±)-MDEA -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-067

(±)-MDEA-D5 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-068

(±)-MDEA-D5 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-081

(±)-MDEA-D6 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-082

(±)-MDEA-D6 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-144

MDAI -hydrochlorid -Lösung, 100 μg/mL in acetonitrile: water (9:1) with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Zielorgane

Eyes

Lagerklassenschlüssel

3 - Flammable liquids

WGK

WGK 1

Flammpunkt (°F)

49.5 °F - closed cup

Flammpunkt (°C)

9.7 °C - closed cup

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Cédric M Hysek et al.
PloS one, 7(5), e36476-e36476 (2012-05-11)
This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects. The clinical study used a double-blind, randomized, placebo-controlled, four-session, crossover design.
Brandon J Warrick et al.
Journal of medical toxicology : official journal of the American College of Medical Toxicology, 8(1), 65-68 (2011-12-14)
A new generation of designer phenethylamines have emerged and aggressively marketed as "legal highs." The drugs are labeled "not for human consumption" to avoid widespread recognition and prosecution under the existing analog drug laws. The newest generation includes methylone and
Aixin Shi et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 908, 87-93 (2012-11-06)
Piperphentonamine hydrochloride (PPTA) is a new calcium sensitizer. A liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for determination of piperphentonamine and its metabolites M1 and M6 was developed for the first time and applied to a pharmacokinetics study. Protein precipitation was
Juan Bin et al.
Metabolic brain disease, 27(4), 495-505 (2012-07-31)
The calcium sensitizers levosimendan and piperphentonamine hydrochloride (PPTA) are used as cardiovascular drugs for treatment of heart failure. Given that levosimendan has been reported to exhibit a neuroprotective profile in a model of traumatic brain injury, it was interesting to
Raul López-Arnau et al.
British journal of pharmacology, 167(2), 407-420 (2012-04-19)
Here, we have compared the neurochemical profile of three new cathinones, butylone, mephedrone and methylone, in terms of their potential to inhibit plasmalemmal and vesicular monoamine transporters. Their interaction with 5-HT and dopamine receptors and their psychostimulant effect was also
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.